在抗肿瘤坏死因子疗法失败后，乌司奴单抗可迅速清除红皮病型银屑病。 - Suppr

Suppr

超能文献

Ustekinumab induces rapid clearing of erythrodermic psoriasis after failure of antitumour necrosis factor therapies.

作者信息

Santos-Juanes J, Coto-Segura P, Mas-Vidal A, Galache Osuna C

出版信息

Br J Dermatol. 2010 May;162(5):1144-6. doi: 10.1111/j.1365-2133.2010.09669.x. Epub 2010 Mar 6.

DOI:10.1111/j.1365-2133.2010.09669.x

PMID:20222926

Abstract

摘要

相似文献

Ustekinumab induces rapid clearing of erythrodermic psoriasis after failure of antitumour necrosis factor therapies.

Br J Dermatol. 2010 May;162(5):1144-6. doi: 10.1111/j.1365-2133.2010.09669.x. Epub 2010 Mar 6.

Sustained efficacy of ustekinumab in refractory erythrodermic psoriasis after failure of antitumor necrosis factor therapies.

J Dermatol. 2012 Aug;39(8):730-1. doi: 10.1111/j.1346-8138.2011.01499.x. Epub 2012 Feb 27.

Observational case series on a group of patients with severe psoriasis who failed to respond to antitumour necrosis factor alpha biologics and switched to ustekinumab.

Br J Dermatol. 2010 Aug;163(2):433-4. doi: 10.1111/j.1365-2133.2010.09832.x. Epub 2010 Apr 29.

Infliximab, as sole or combined therapy, induces rapid clearing of erythrodermic psoriasis.

Br J Dermatol. 2007 Oct;157(4):828-31. doi: 10.1111/j.1365-2133.2007.08111.x. Epub 2007 Aug 17.

Diagnosing latent tuberculosis infection in patients with psoriasis under antitumour necrosis factor-α treatment: every new solution breeds new doubts.

Br J Dermatol. 2011 Jan;164(1):208-9. doi: 10.1111/j.1365-2133.2010.10028.x. Epub 2010 Nov 4.

Switching to adalimumab in patients with moderate to severe psoriasis who have failed on etanercept: a retrospective case cohort study.

Br J Dermatol. 2010 Oct;163(4):889-92. doi: 10.1111/j.1365-2133.2010.09893.x. Epub 2010 Jul 28.

Long-term management of erythrodermic psoriasis with anti-TNF agents.

Dermatol Online J. 2010 Jun 15;16(6):15.

Ustekinumab in severe complicated erythrodermic psoriasis: rapid clearing, safety, and sustained remission.

Dermatol Ther. 2014 Sep-Oct;27(5):257-9. doi: 10.1111/dth.12131. Epub 2014 May 9.

Consecutive use of different biological therapies in the treatment of psoriasis.

Br J Dermatol. 2007 Aug;157(2):394. doi: 10.1111/j.1365-2133.2007.07988.x. Epub 2007 Jun 6.

Tumor Necrosis Factor Inhibitor Primary Failure Predicts Decreased Ustekinumab Efficacy in Psoriasis Patients.

J Drugs Dermatol. 2015 Aug;14(8):893-8.

引用本文的文献

Management of Erythrodermic Psoriasis with Systemic Therapies: A Systematic Review.

Am J Clin Dermatol. 2025 Aug 26. doi: 10.1007/s40257-025-00977-1.

Biologics for the Management of Erythrodermic Psoriasis: An Updated Review.

Clin Cosmet Investig Dermatol. 2023 Aug 4;16:2045-2059. doi: 10.2147/CCID.S407813. eCollection 2023.

Updates on the Treatment of Erythrodermic Psoriasis.

Psoriasis (Auckl). 2021 Jun 9;11:59-73. doi: 10.2147/PTT.S288345. eCollection 2021.

Targeted Treatment for Erythrodermic Psoriasis: Rationale and Recent Advances.

Drugs. 2020 Apr;80(6):525-534. doi: 10.1007/s40265-020-01283-2.

Erythrodermic psoriasis: pathophysiology and current treatment perspectives.

Psoriasis (Auckl). 2016;6:93-104. doi: 10.2147/PTT.S101232. Epub 2016 Jul 20.

Erythrodermic Psoriasis Improved by Ustekinumab: A Report of Two Cases.

Ann Dermatol. 2016 Feb;28(1):121-2. doi: 10.5021/ad.2016.28.1.121. Epub 2016 Jan 28.

Erythrodermic Psoriasis Treated with Golimumab: A Case Report.

Ann Dermatol. 2015 Aug;27(4):446-9. doi: 10.5021/ad.2015.27.4.446. Epub 2015 Jul 29.

An evolution in switching therapy for psoriasis patients who fail to meet treatment goals.

Dermatol Ther. 2015 Nov-Dec;28(6):390-403. doi: 10.1111/dth.12267. Epub 2015 Aug 10.

Ustekinumab treatment of erythrodermic psoriasis occurring after physical stress: a report of two cases.

Case Rep Dermatol. 2013 Sep 26;5(3):254-9. doi: 10.1159/000348645. eCollection 2013.

Ustekinumab: differential use in psoriasis.

Clin Cosmet Investig Dermatol. 2011;4:93-9. doi: 10.2147/CCID.S17917. Epub 2011 Jul 1.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验